Nicholas A. Bosma

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Bone is a common site for metastatic colonization in patients with breast cancer, hence the importance of identifying new treatments for this disease. Preclinical studies of bone metastases have commonly employed MDA-MB-231 cells that possess an activated KRAS allele. While activating RAS mutations are relatively rare in human breast cancer, increased(More)
  • 1